T. Rowe Price Associates’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

T. Rowe Price Associates’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,086	Closed	-$690K	–	3002
2023 Q4	$690K	Sell	11,086 -1,022,492	-99%	-$25.4M	﹤0.01%	2034
2023 Q3	$22.9M	Buy	+1,033,578	New	+$21.7M	﹤0.01%	887

T. Rowe Price Associates's RYZB Position: Q1 2024 in Review

T. Rowe Price Associates sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 11,086 shares — an estimated $690K sold.

T. Rowe Price Associates first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $22.9M in Q3 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

T. Rowe Price Associates reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
T. Rowe Price Associates sold 11,086 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $690K.
T. Rowe Price Associates first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
T. Rowe Price Associates's RayzeBio, Inc. Common Stock position peaked at $22.9M in Q3 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.